Study Stopped
Interim analysis indicated significant additional subjects needed to demonsate statistical difference in primary outcome.
Effect of Enteral Nutrition Support for Critically Ill Patients
1 other identifier
interventional
84
1 country
9
Brief Summary
To determine whether specialized enteral nutrition support can improve oxygenation status in critically ill patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) comparing to a standard enteral nutritional formula.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Apr 2010
Shorter than P25 for phase_3
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 1, 2011
CompletedFirst Posted
Study publicly available on registry
November 4, 2011
CompletedNovember 4, 2011
March 1, 2011
1 year
November 1, 2011
November 2, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
Oxygenation status improvement
28 days
Secondary Outcomes (8)
Length of ventilation
28 days
Length of ICU stay
28 days
Incidence of organ failures
28 days
Incidence of ventilator-associated pneumonia
28 days
Mortality
28 days
- +3 more secondary outcomes
Study Arms (2)
Specialized Enteral Nutrition
EXPERIMENTALEnteral Feeding to provide 25 kcal/Kg/day
Standard Enteral Nutrition
ACTIVE COMPARATOREnteral Feeding to provide 25 kcal/Kg/day
Interventions
Enteral Feeding to provide 25 kcal/Kg/day
Eligibility Criteria
You may qualify if:
- Male or non-pregnant female.
- ALI or ARDS
- PaO2/FiO2 \> 100 and ≤ 300 torr.
- Evidence of bilateral pulmonary infiltrates/opacity on chest radiograph.
- Enteral access
- Systemic inflammatory response syndrome (SIRS) - two or more of the following must be present:
- Body temperature less than 36°C or greater than 38°C
- Heart rate \> 90 beats per minute
- Tachypnea with \> 20 breaths per minute; or an arterial partial pressure of carbon dioxide \< 4.3 kPa (32 mmHg)
- White blood cell count \< 4000 cells/mm³ or \> 12,000 cells/mm³; or the presence of \> 10% immature neutrophils.
You may not qualify if:
- Dialysis for renal failure
- Anticipated life expectancy less than 24 hours.
- Patient with severe chronic liver disease
- Neuromuscular disease that impairs ability to ventilate without assistance
- Head trauma and/or drowning with a Glasgow coma score of 5
- Receiving intravenous lipid emulsions from parenteral nutrition within 12 hours of baseline.
- Receiving propofol
- Airway reconstructive surgery.
- Malignancy or irreversible disease for which 6-month mortality is greater than 50%.
- Burns greater than 25% total body surface area.
- Unwillingness or inability to utilize the ARDS network ventilation protocol.
- HIV positive.
- Chronic mechanical ventilation.
- Severe, acute pancreatitis.
- Refractory shock
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbott Nutritionlead
Study Sites (9)
1st City Clinical Emergency Hospital n.a. E.E. Volosevich
Arkhangelsk, 163001, Russia
City Clinical Hospital #2
Krasnodar, 350012, Russia
Krasnoyarsk State Medical University n.a. Prof V.F. Voyno-Yasenetskogo
Krasnoyarsk, 660022, Russia
Central Clinical Hospital #1
Moscow, 125367, Russia
State Novosibirsk Regional Clinical Hospital
Novosibirsk, 630087, Russia
Clinical Medical Unit #1
Perm, 614010, Russia
St. Petersburg Scientific Research Institute of Emergency Care n.a. I.I.Dzhanelidze
Saint Petersburg, 192442, Russia
Republican Clinical Hospital n.a. G.G. Kuvatova
Ufa, 45005, Russia
Central City Hospital #7
Yekaterinburg, 620109, Russia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Menghua Luo, MD, PhD
Abbott Nutrition
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 1, 2011
First Posted
November 4, 2011
Study Start
April 1, 2010
Primary Completion
April 1, 2011
Study Completion
May 1, 2011
Last Updated
November 4, 2011
Record last verified: 2011-03